Meningococcal polysaccharide vaccination of military recruits in Israel: Preliminary assessment of vaccine effect

Daniel Mimouni, Michael Gdalevich, Yosef Mandel, Moti Haim, Isaac Ashkenazi, Joshua Shemer, Colin Block

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).

Original languageEnglish
Pages (from-to)263-264
Number of pages2
JournalScandinavian Journal of Infectious Diseases
Volume30
Issue number3
DOIs
StatePublished - 20 Oct 1998
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Microbiology (all)
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Meningococcal polysaccharide vaccination of military recruits in Israel: Preliminary assessment of vaccine effect'. Together they form a unique fingerprint.

Cite this